APRICUS BIOSCIENCES, INC. (45) | Intellectual Property (3)
Browse by Subcategory
Recent Contracts
-
License Agreement, dated as of November 24, 2021, by and between Seelos Therapeutics, Inc. and iX Biopharma Europe Limited
(Filed With SEC on November 24, 2021)
-
Amendment to License Agreement, dated as of February 8, 2019, by and among Ligand Pharmaceuticals Incorporated, Neurogen Corporation, CyDex Pharmaceuticals, Inc., and Seelos...
(Filed With SEC on March 17, 2020)
-
Amended and Restated Exclusive License Agreement, dated August 29, 2019, by and between Seelos Therapeutics, Inc. and Stuart Weg, MD
(Filed With SEC on November 7, 2019)
